Actos Cancer -

In 2015, Takeda Pharmaceuticals agreed to a massive $2.37 billion settlement to resolve approximately 9,000 bladder cancer claims in the U.S..

Studies indicated that the risk increased with higher cumulative doses and longer duration of use (specifically more than 12 months).

If you have symptoms, a doctor may perform a cystoscopy or imaging scans to check for abnormalities. ACTOS CANCER

In 2011, the FDA issued a safety communication warning about these risks. Around the same time, countries like France and Germany suspended or restricted the use of the drug.

Actos is a brand-name prescription drug (generic name: ) manufactured by Takeda Pharmaceuticals . It belongs to a class of drugs called thiazolidinediones, designed to help adults with type 2 diabetes manage their blood sugar levels by improving insulin sensitivity. 2. The Connection to Bladder Cancer In 2015, Takeda Pharmaceuticals agreed to a massive $2

, such as needing to urinate more frequently or urgently. Pain during urination (dysuria). Pain in the lower back or pelvic region . 4. Legal Status and Claims

(hematuria), which may make urine look pink, red, or cola-colored. In 2011, the FDA issued a safety communication

Check your records to see how long you took Actos and at what dosage.